EDX Medical to Market Pioneering Cancer Drugs Response Assay in UK and Nordics

Contributed by: Business Wire

Tags

Technology

Medical Devices

Genetics

Clinical Trials

Health Technology

Biotechnology

Pharmaceutical

Health

Oncology

Artificial Intelligence

Curesponse Ltd

More Like This

EDX Medical Announces Agreement With Caris Life Sciences to Distribute Molecular Profiling in the United Kingdom and Nordic Countries

PR Newswire associated0

EDX MEDICAL ANNOUNCES COLLABORATION WITH THERMO FISHER SCIENTIFIC TO DEVELOP INNOVATIVE CANCER TESTS FOR GLOBAL HEALTHCARE MARKETS

NEW TESTS TO IDENTIFY HEREDITARY CANCER RISKS TO BE LAUNCHED

PR Newswire associated0

SCIENTISTS PIONEER DEVELOPMENT OF MULTI-DISEASE RAPID TESTS AS EDX MEDICAL PLC COMPLETES ACQUISITION OF HUTANO DIAGNOSTICS LTD

Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients

Oxford BioDynamics part of consortium shortlisted for Strategic Government Initiative to Improve Cancer Immunotherapy

Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening